Invitation to Recipharm’s Capital Markets Day 2019

Recipharm has the pleasure of inviting investors, financial analysts and media to attend our Capital Markets Day on Monday 18 November 2019 at The Roots (Scandic Camper), Drottninggatan 28, Stockholm.

The purpose of the Capital Markets Day is to provide an update on Group performance, plan and strategy. Presentations will be held by Thomas Eldered, CEO; Tobias Hägglöv, CFO and other members of the Group Management Team.

Coffee is served from 9:00, the program begins at 9:30 and ends by 15:00.

To attend, please register following this link at our website, no later than November 11.

For further information please visit www.recipharm.com or contact:

Tobias Hägglöv, CFO, ir@recipharm.com, +46 8 602 52 00 

About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 6,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 6.4 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.

For more information on Recipharm and our services, please visit www.recipharm.com 

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com

Tags: